BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 1465831)

  • 21. The graft survival curve: ideology and rhetoric.
    Guttmann RD
    Transplant Proc; 1992 Dec; 24(6):2407-10. PubMed ID: 1465810
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of anti-HLA and anti-idiotypic antibodies on the long-term survival of heart and kidney allografts.
    Reed E; Cohen DJ; Barr ML; Ho E; Marboe CC; Rose EA; Hardy M; Suciu-Foca N
    Transplant Proc; 1992 Dec; 24(6):2494-5. PubMed ID: 1465842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cold ischemia time and MHC class II matching in renal transplants.
    Iwaki Y; Cicciarelli J; Aswad S; Gavazov M; Obispo E; Khetan U; Bogaard T; Asai P; Mendez RG; Mendez R
    Transplant Proc; 1992 Dec; 24(6):2456-7. PubMed ID: 1465829
    [No Abstract]   [Full Text] [Related]  

  • 24. Importance of HLA matching in highly sensitised renal transplant recipients with high transplant survival rates. The Manchester Kidney Transplant Team.
    Martin S; Connolly J; Jos V
    Transplant Proc; 1993 Feb; 25(1 Pt 1):265-6. PubMed ID: 8438295
    [No Abstract]   [Full Text] [Related]  

  • 25. Collaborative Transplant Study Kidney Exchange Trial for highly sensitized recipients.
    Opelz G
    Clin Transpl; 1991; ():61-4. PubMed ID: 1820146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cadaveric kidney transplantation in patients with lymphocytotoxic autoantibodies.
    Emonds MP; Dendievel J; Roels L; Waer M; Vanrenterghem Y; Vermylen C
    Transplant Proc; 1992 Dec; 24(6):2502-3. PubMed ID: 1465845
    [No Abstract]   [Full Text] [Related]  

  • 27. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
    Pallardó LM; Sánchez P; Sánchez J; García J; Orero E; Beneyto I; Cruz JM
    Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911
    [No Abstract]   [Full Text] [Related]  

  • 28. HLA matching and short/long-term outcome of cadaveric renal allografts: large single-centre data confirm the multicentre analyses.
    Petersen P; Schneeberger H; Schleibner S; Illner WD; Hofmann GO; Scholz S; Albert ED; Land W
    Transplant Proc; 1995 Feb; 27(1):651-2. PubMed ID: 7879131
    [No Abstract]   [Full Text] [Related]  

  • 29. Renal transplant graft survival results and HLA-A,B, DR mismatching.
    Cicciarelli J; Iwaki Y; McCalmon R; Thompson J
    Transplant Proc; 1995 Feb; 27(1):660-3. PubMed ID: 7879135
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation.
    Berney T; Malaise J; Morel P; Toso C; Demuylder-Mischler S; Majno P; Bühler LH; Mentha G;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii48-53, ii62. PubMed ID: 15814550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The great influence of HLA-DRB1 deducted from HLA B-DRB1 linkage on kidney graft success.
    Hashimoto M; Kinoshita T; Yamasaki M; Sada M; Fujimoto N; Kyo M; Fukunishi T; Nagano S; Ishibashi M; Amemiya H
    Transplant Proc; 1992 Dec; 24(6):2445-6. PubMed ID: 1465823
    [No Abstract]   [Full Text] [Related]  

  • 32. Revisiting HLA matching for kidney transplantation.
    Opelz G; Wujciak T; Mytilineos J; Scherer S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):173-5. PubMed ID: 8438263
    [No Abstract]   [Full Text] [Related]  

  • 33. HLA-DR matching and anti-donor-specific antibodies in kidney transplant recipients.
    Valeri M; Piazza A; Torlone N; Poggi E; Monaco PI; Provenzani L; Adorno D; Casciani CU
    Transplant Proc; 1992 Dec; 24(6):2514-6. PubMed ID: 1465850
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy.
    Vanrenterghem Y; Roels L; Waer M; Gruwez J; Dendievel J; Michielsen P
    Transplant Proc; 1987 Feb; 19(1 Pt 1):685-6. PubMed ID: 3274841
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical value of HLA-DRB1 typing in cadaveric renal transplantation.
    Kobayashi T; Negita M; Yokoyama I; Kamura H; Kohara S; Ohshima S; Fujita T; Ono Y; Kinukawa T; Hoshinaga K
    Transplant Proc; 1993 Dec; 25(6):3271-2. PubMed ID: 8266538
    [No Abstract]   [Full Text] [Related]  

  • 36. The relevance of HLA A,B,C, matching on graft survival, patient survival, and graft function in living related renal transplant patients treated with cyclosporine.
    Masri MA; Dhawan IK; Hayes K; Zahir M; Shanwaz M; Shakuntala S; Pingle A
    Transplant Proc; 1992 Oct; 24(5):1676-7. PubMed ID: 1412793
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of donor-specific blood transfusions on graft outcome in live donor renal transplantations.
    Velidedeoğlu E; Tokyay R; Haberal M
    Transplant Proc; 1992 Dec; 24(6):2752-3. PubMed ID: 1465927
    [No Abstract]   [Full Text] [Related]  

  • 38. DR6 compatibility and kidney graft survival.
    Correia AM; de Costa AG; Reis P; Rego F; Sampaio MJ; Caetano JM; Pena JR
    Transplant Proc; 1992 Dec; 24(6):2472. PubMed ID: 1465836
    [No Abstract]   [Full Text] [Related]  

  • 39. Single center experience with the CTS-HIT allocation system for highly immunized patients. The Leuven Collaborative Group for Transplantation.
    Roels L; Vanrenterghem Y; Waer M; Dendievel J; Emonds MP; Christiaens R; Gruwez J; Michielsen P
    Transplant Proc; 1992 Dec; 24(6):2492-3. PubMed ID: 1465841
    [No Abstract]   [Full Text] [Related]  

  • 40. Fully parametric analysis of kidney graft survival.
    Vereerstraeten P
    Transplant Proc; 1992 Dec; 24(6):2411-3. PubMed ID: 1465811
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.